Pay in 4 interest-free payments of $30.50 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Mavoglurant in fragile X syndrome: Results of two randomized
Esculetin inhibits platelet-derived growth factor (PDGF)-induced airway smooth muscle cells (ASMCs) phenotype switching through inhibition of PI3K/Akt pathway
14 L/h/kg)
InChiKey: ZESQVNWRUDEXNZ-UHFFFAOYSA-N
Exposure of macrophages to 1
GDC-0276 n-d3 Ethyl Ester Oxalate Mavoglurant in fragile X syndrome:GDC 0276 is a potent, selective, reversible and orally active NaV1. 7 inhibitor with an IC50 value of 0. 4 nM. GDC 0276 is well tolerated and exhibits a good pharmacokinetic profile. GDC 0276 has the potential for the treatment of pain and to address shortcomings of existing pain medications, such as addiction and off target side effects. Product information CAS Number: 1494581 70 2 Molecular Weight: 462. 58 Formula: C24H31FN2O4S Chemical Name: 4
US$ 10.00
US$ 78.95
US$ 325.00
US$ 12.09
US$ 124.29
US$ 36.95
US$ 33.00
US$ 33.00
US$ 32.00
US$ 40.00
US$ 32.00
US$ 64.00